Loading...
XJPX2413
Market cap5.95bUSD
Dec 24, Last price  
1,375.50JPY
1D
0.00%
1Q
-7.68%
Jan 2017
-6.59%
Name

M3 Inc

Chart & Performance

D1W1MN
XJPX:2413 chart
P/E
20.63
P/S
3.91
EPS
66.67
Div Yield, %
1.38%
Shrs. gr., 5y
0.95%
Rev. gr., 5y
16.14%
Revenues
238.88b
+3.49%
2,276,497,0003,854,821,0005,729,052,0007,475,339,0008,534,933,00011,811,960,00014,646,737,00019,040,810,00026,007,662,00036,887,234,00051,346,000,00064,660,000,00078,143,000,00094,471,000,000113,059,000,000130,973,000,000169,198,000,000208,159,000,000230,818,000,000238,883,000,000
Net income
45.27b
-7.66%
493,082,000991,668,0001,609,156,0001,965,554,0002,363,272,0002,956,067,0003,486,762,0004,492,941,0005,598,741,0008,318,323,0009,759,000,00012,508,000,00016,004,000,00019,684,000,00019,577,000,00021,635,000,00037,822,000,00063,845,000,00049,028,000,00045,271,000,000
CFO
58.31b
+2.10%
856,605,0001,193,244,0001,443,044,0002,351,669,0002,055,657,0003,535,129,0003,186,999,0005,326,855,0005,810,152,0008,647,090,0009,316,000,00012,136,000,00016,555,000,00015,913,000,00017,749,000,00026,789,000,00046,627,000,00052,108,000,00057,113,000,00058,310,000,000
Dividend
Mar 28, 202421 JPY/sh
Earnings
Jan 29, 2025

Profile

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
URL
https://corporate.m3.com/
IPO date
Sep 16, 2004
Employees
10,533
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
238,883,000
3.49%
230,818,000
10.89%
208,159,000
23.03%
Cost of revenue
173,355,000
169,005,000
148,006,000
Unusual Expense (Income)
NOPBT
65,528,000
61,813,000
60,153,000
NOPBT Margin
27.43%
26.78%
28.90%
Operating Taxes
20,291,000
22,336,000
30,078,000
Tax Rate
30.97%
36.13%
50.00%
NOPAT
45,237,000
39,477,000
30,075,000
Net income
45,271,000
-7.66%
49,028,000
-23.21%
63,845,000
68.80%
Dividends
(12,896,000)
(10,860,000)
(8,144,000)
Dividend yield
0.89%
0.48%
0.27%
Proceeds from repurchase of equity
88,000
(5,602,000)
(5,121,000)
BB yield
-0.01%
0.25%
0.17%
Debt
Debt current
2,031,000
3,269,000
2,927,000
Long-term debt
36,155,000
14,226,000
10,740,000
Deferred revenue
(7,113,000)
(5,370,000)
Other long-term liabilities
10,263,000
14,742,000
11,333,000
Net debt
(209,665,000)
(192,560,000)
(177,076,000)
Cash flow
Cash from operating activities
58,310,000
57,113,000
52,108,000
CAPEX
(7,581,000)
(7,577,000)
(3,217,000)
Cash from investing activities
(39,456,000)
(21,933,000)
(23,407,000)
Cash from financing activities
9,432,000
(22,837,000)
(16,371,000)
FCF
36,444,000
35,408,000
28,555,000
Balance
Cash
179,828,000
146,388,000
141,216,000
Long term investments
68,023,000
63,667,000
49,527,000
Excess cash
235,906,850
198,514,100
180,335,050
Stockholders' equity
340,122,000
569,924,000
485,994,000
Invested Capital
169,407,150
119,183,900
86,754,950
ROIC
31.35%
38.34%
35.21%
ROCE
15.40%
18.48%
21.44%
EV
Common stock shares outstanding
679,461
679,328
679,347
Price
2,137.00
-35.26%
3,301.00
-26.14%
4,469.00
-40.97%
Market cap
1,452,009,181
-35.25%
2,242,461,342
-26.14%
3,036,000,599
-40.97%
EV
1,257,130,181
2,342,239,342
3,116,746,599
EBITDA
74,406,000
69,247,000
66,427,000
EV/EBITDA
16.90
33.82
46.92
Interest
391,000
69,000
52,000
Interest/NOPBT
0.60%
0.11%
0.09%